Sunshine Guojian Pharmaceutical
68833641.302.02% ( -0.85 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Sunshine Guojian Pharmaceutical(688336) the Revenue is 431.23 M (+38.61%);the EBIT is 189.84 M (+98.55%);the EPS is 0.2 (+70.65%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.43B38.61%
----
----
EBIT
0.19B98.55%
----
----
EPS
0.270.65%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf